Public Company News

Sohu.com to Report First Quarter 2025 Financial Results on May 19, 2025

BEIJING, May 9, 2025 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU), a leading Chinese online media platform and game business group, will report its first quarter 2025 unaudited financial results onMonday, May 19, 2025, before U.S. market hours. Sohu's management team will host a conference ...

2025-05-09 13:00 6652

Dogness Announces Entry into US$6.0 Million Private Placement

DONGGUAN, China and PLANO, Texas, May 8, 2025 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced that it entered into a privat...

2025-05-09 04:45 5910

IMTE Announces Receipt of Deficiency Letter from Nasdaq

NEW YORK, May 8, 2025 /PRNewswire/ -- Integrated Media Technology Limited (NASDAQ: IMTE) ("IMTE" or the "Company"), anAustralia company that is engaged in the businesses of the trading in Halal products, the manufacture and sale of nano coated plates for filters, and the manufacturing and sale of...

2025-05-09 00:44 5219

THE ULTIMATE K-BEAUTY LIFTING CREAM FOR MOTHER'S DAY: DISCOVER THE POWER OF BIOHEAL BOH

Shop now on Amazon and Olive Young Global —limited-time offers through May SEOUL, South Korea , May 8, 2025 /PRNewswire/ -- This Mother's Day, treat your loved ones or yourself to the gift of radiant, youthful skin with BIOHEAL BOH's signatureProbioderm 3D Lifting collection. Created by CJ Olive...

2025-05-09 00:00 4442

Datasea Pre-Announces Estimated Third Quarter Revenue of approximately $51.9 Million, up approximately 164.6% Year-over-Year

Expects to Achieve Projected Annual Revenue of $90 Million BEIJING, May 8, 2025 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or "the Company"), aNevada-based digital technology company specializing in acoustics high-tech and 5G+AI multimodal digital innovations, today pre-announced its...

2025-05-08 21:30 5651

BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidate

* BioDlink congratulates Junshi Biosciences on receiving IND approval from China's NMPA for JS212, the company's first bispecific ADC. * JS212 combines dual-targeting antibody technology with a cytotoxic payload, representing anext-generation therapeutic. * BioDlink provided end-to-end devel...

2025-05-08 20:30 5291

Goodbaby International Holdings Limited Announces First Quarter Revenue Performance

Group Revenue Records Positive Growth  Despite Extremely Volatile Macro Environment  CYBEX Maintains Strong Momentum and Achieves Double-Digit Revenue Growth HONG KONG, May 8, 2025 /PRNewswire/ -- Goodbaby International Holdings Limited ("Goodbaby International" or the "Company"; HKEX stock code: ...

2025-05-08 17:09 5984

Baidu to Hold Annual General Meeting on June 27, 2025

BEIJING, May 8, 2025 /PRNewswire/ -- Baidu, Inc. ("Baidu" or the "Company") (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)), a leading AI company with strong Internet foundation, today announced that it will hold its annual general meeting of shareholders (the "AGM") at Baidu Cam...

2025-05-08 17:00 3527

Acer Announces Q1'25 Operating Income at NT$1.04 Billion, Up 33.0% Year-on-Year

Margins for gross profit and operating income grow year-on-year TAIPEI, May 8, 2025 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its financial results for the first quarter of 2025. Consolidated revenues reached NT$61.34 billion, up 4.3% year-on-year (YoY); gross profits reached NT$6.48 billi...

2025-05-08 16:26 4648

Qifu Technology's Paper Accepted by IJCAI 2025, Using MLLM to Pave New Path in Fintech

SHANGHAI, May 7, 2025 /PRNewswire/ -- China's leading fintech company Qifu Technology ( NASDAQ: QFIN; HKEX: 3660) and Beijing Jiaotong University have jointly achieved a significant milestone as their paper,Leveraging MLLM Embeddings and Attribute Smoothing for Compositional Zero-Shot Learning, h...

2025-05-08 13:52 4981

Penetrium™ Breaks Oncology Barriers: The Solution to Cold Tumors and Metastatic Cancer Unveiled at AACR 2025

* Penetrium™ Achieves Historic Breakthrough * Overcoming Cold Tumor Failure and the Challenge of Metastatic Cancer in Immunotherapy and Antibody Therapy * Presented at AACR 2025, Chicago CHICAGO, May 7, 2025 /PRNewswire/ -- Hyundai Bioscience presented the results of its Penetrium™ combinati...

2025-05-08 09:03 6613

HANYUL Exclusively Launches at Sephora, Bringing Authentic Korean Beauty to U.S. Consumers

NEW YORK, May 7, 2025 /PRNewswire/ -- HANYUL, a renowned leader in Korean beauty, is set to launch at Sephora onMay 16, 2025. This exciting new partnership will bring HANYUL's signature skincare to U.S. consumers both online and in Sephora stores nationwide. Known for combining the finest tradit...

2025-05-07 23:00 4180

Lunit to Power Germany's Largest Private Radiology Network with AI Imaging

The five-year framework agreement covers phased rollout of Lunit's AI suite—including chest X-ray, mammography, tomosynthesis, and fracture detection—across 79 Starvision sites SEOUL, South Korea, May 7, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics ...

2025-05-07 21:00 3651

Nature's Miracle Holding Inc. Announces Up to $20 Million Financing with GHS Investment

ONTARIO, Calif., May 7, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB:NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology, today announced that the Company has entered into an equity purchase financing agreement (the "Financing") with GHS Investments L...

2025-05-07 20:30 5296

TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids

* Primary Endpoint Met: Statistically significant reduction in heavy menstrual bleeding achieved in all dosage of Merigolix groups compared to placebo * Broader Therapeutic Potential: Positive Phase 2 results in both uterine fibroids and endometriosis could place Merigolix as a strong best-in...

2025-05-07 20:00 3231

Zepp Health Corporation to Report First Quarter 2025 Financial Results on May 19, 2025

Earnings Call Scheduled for 9:00 p.m. ET on May 19, 2025 MILPITAS, Calif., May 7, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it will report its first quarter 2025 unaud...

2025-05-07 20:00 6049

Baozun to Announce First Quarter 2025 Unaudited Financial Results on May 21, 2025

SHANGHAI, May 7, 2025 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution provider and digital commerce enabler inChina, today announced that it will release its unaudited financial results for the first quarter e...

2025-05-07 18:00 4762

CreateAI Releases White Paper on how AI Transforms Animation Production

BEIJING, May 6, 2025 /PRNewswire/ -- CreateAI Holdings Inc. (OTCMKTS: TSPH) ("CreateAI" or the "Company"), a global artificial intelligence technology company, today announced the release of its "White Paper on the Application and Development of Multimodal Generative Technology in Animation Produ...

2025-05-07 10:00 5256

CStone Presents Preclinical Results of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bispecific ADC), CS5005 (SSTR2 ADC) and CS5006 (ITGB4 ADC) at 2025 AACR

SUZHOU, China, May 6, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that poster presentations of preclinical data of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bis...

2025-05-07 08:00 4070

Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Post-Ocular Surgery Inflammation and Pain for Mexico

TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals (" Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights inMexico for the commercialization of clobetasol propionate ophthalmic...

2025-05-07 06:30 6510
1 ... 204205206207208209210 ... 745